Canopy Growth Corp

Canopy Growth Corp(CGC)股票分析

$0.713

-0.022 (-3.06%)收盤時

Loading chart…
最高
0.756
開盤
0.752
成交量加權均價
0.72
成交量
2.41M
市值
508.24M
最低
0.702
成交金額
1.74M
企業價值/稅息折舊攤銷前利潤(TTM)
-6.00

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.

AI 分析 of Canopy Growth Corp (CGC)

賣出

Canopy Growth Corp is not a good buy right now due to its current price of 0.8271 and an RSI of 16.439, indicating it is oversold. The company is facing significant challenges, including a negative cash flow of CAD 25 million and a high insider selling rate of 187.19% over the last month, which raises red flags about investor confidence. The main risk is the ongoing cash flow losses, which have increased from CAD 10 million to CAD 25 million, indicating worsening financial health.

估值指標

Canopy Growth Corp(CGC)目前預期本益比為 20.37,5 年平均預期本益比為 -1.24。

預期本益比

嚴重高估
5 年均值 P/E
-1.24
目前P/E
20.37
高估
8.72
低估
-11.20

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-274.73
目前EV/EBITDA
-6.00
高估
449.33
低估
-998.79

預期股價營收比

合理
5 年均值 P/S
2.93
目前P/S
0.87
高估
5.23
低估
0.64

Alphio AI 對 CGC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CGC

$1.78

情境價格

基

基準

基準 · 50%CGC

$1.69

情境價格

悲

悲觀

悲觀 · 25%CGC

$1.41

情境價格

事件時間軸

2026-09-28 (ET)

08:00:00

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

08:00:00

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

2026-09-22 (ET)

08:00:00

Canopy Growth Supplies Medical Cannabis Flowers to the UK

2026-09-08 (ET)

08:00:00

Canopy Growth Expands Medical Cannabis Portfolio in Australia

2026-08-07 (ET)

07:30:00

Company Reports Q1 Revenue of C$100.4M

資訊

CGC 常見問題 —— 由 Alphio AI 解答

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Canopy Growth Corp is not a good buy right now due to its current price of 0.8271 and an RSI of 16.439, indicating it is oversold. The company is facing significant challenges, including a negative cash flow of CAD 25 million and a high insider selling rate of 187.19% over the last month, which raises red flags about investor confidence. The main risk is the ongoing cash flow losses, which have increased from CAD 10 million to CAD 25 million, indicating worsening financial health.

0xSkewfalcon2026/9/27

As mid-term elections approach and marijuana legalization comes up for debate again, $CGC is a chart worth watching. A large triangle pattern is close to a breakout. If it can reclaim its 50 DMA, there could be upside ahead 📈🌿 $1+ looks fairly likely again in the near future.

展開
註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易